Date: 31-Jul-2019

Cipla seeks favourable policy for domestic pharma cos

The Indian pharmaceutical major Cipla Ltd has urged the Central government to increase expenditure for the healthcare sector, and formulate policies that will aid the domestic pharmaceutical industry. Addressing the shareholders in the companys annual report for 2018-19, Cipla chairman Y K Hamied said "Our pharmaceutical industrys prime role is to save and improve the quality of patients lives. We need to provide affordable essential drugs to safeguard a stable and healthy India."